FRA/HCW (FRA/HCW)

Frankfurt Stock Exchange: FRA/HCW · EUR

€203

-9.10 (-4.3%)· Recorded snapshot

Market cap	148.9B
Revenue (ttm)	12.1B
Net income (ttm)	1.5B
EPS (ttm)	€2.08
P/E (trailing)	97.5x
P/E (forward)	79.6x
Dividend	€2.63 (1.30%)
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12.1B
Net income (ttm): 1.5B
EPS (ttm): €2.08
P/E (trailing): 97.5x
P/E (forward): 79.6x
Market cap: 148.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E79.6

P25 n/aP50 n/aP75 n/a

Trailing P/E97.5

P25 n/aP50 n/aP75 n/a

ROE3.9

P25 n/aP50 n/aP75 n/a

ROIC1.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/HCW indicators

Market & fundamental data

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-26
Employees	712
Employees change	27
Employees growth	3.94%
Enterprise value	EUR 167.1B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1970
Industry	REIT - Healthcare Facilities
Is primary listing	No
ISIN number	US95040Q1040
Last earnings date	2026-10-26
Last refreshed	2026-10-28
Market cap	EUR 148.9B
Next earnings date	2026-10-28
Price	EUR 203.10
Price currency	EUR
Sector	Real Estate
SIC code	6798
Stock price date	2026-10-27
Symbol	fra/HCW
Website	https://www.welltower.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	88.97x
Average P/E ratio (3Y)	106.79x
Average P/E ratio (5Y)	141.47x
Earnings yield	1.03%
EV/Earnings	113.82x
EV/EBIT	197.11x
EV/EBITDA	47.71x
EV/Sales	13.49x
Forward P/E	79.57x
Graham number	51.92423
Graham upside	-74.43%
Lynch fair value	EUR 50.03
Lynch upside	-75.37%
P/(OCF - SBC) ratio	101.89x
P/B ratio	3.39x
P/E ratio	97.46x
P/FFO ratio	64.73x
P/OCF ratio	52.03x
P/S ratio	12.26x
Price / tangible book value	3.48x
Price/EBITDA ratio	44.01x
Sector forward P/E	7.37x
Sector P/E	5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	7.18%
EBITDA margin	27.86%
Gross margin	39.23%
Operating margin	7.18%
Pretax margin	12.32%
Profit margin	12.08%
Profit per employee	EUR 2.1M
Profitable quarters	15
Profitable years	33
Revenue per employee	EUR 17.1M
ROA	0.93%
ROA (5Y)	1.38%
ROCE	1.4%
ROE	3.92%
ROE (5Y)	2.04%
ROIC	1.43%
ROIC (5Y)	2.25%
SBC / revenue	12.22%
Tax / revenue	-0.35%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	58.96%
EPS growth (Q)	31.42%
EPS growth (QoQ)	-12.16%
EPS growth 10Y	0.23%
EPS growth 3Y	66.48%
EPS growth 5Y	17.5%
EPS growth quarters	3
EPS growth years	0
Net income growth	73.55%
Net income growth (Q)	41.36%
Net income growth (QoQ)	-10.88%
Net income growth 3Y	87.6%
Net income growth 5Y	30.45%
Net income growth quarters	3
Net income growth years	0
OCF growth	21.93%
OCF growth 10Y	7.07%
OCF growth 3Y	31.49%
OCF growth 5Y	21.73%
Revenue growth	39.22%
Revenue growth (Q)	38.36%
Revenue growth (QoQ)	4.83%
Revenue growth 10Y	12.54%
Revenue growth 3Y	29.97%
Revenue growth 5Y	24.81%
Revenue growth quarters	21
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	EUR 2.4B
EBIT	EUR 872M
EBITDA	EUR 3.4B
EPS	EUR 2.08
Funds from operations (FFO)	EUR 2.3B
Gross profit	EUR 4.8B
Income taxes	EUR -42.5M
Investing cash flow	EUR -11.8B
Net cash flow	EUR -2.2B
Net income	EUR 1.5B
Operating cash flow minus SBC	EUR 1.5B
Operating income	EUR 872M
Revenue	EUR 12.1B
Stock-based compensation	EUR 1.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 58.44
Debt / EBITDA	5.36
Debt / equity	0.42
Interest coverage	1.28
Net cash (debt)	EUR -16.6B
Net cash / market cap	-11.17%
Net debt / EBITDA	4.92
Net debt / equity	0.38
Piotroski F-Score	5
Property, plant and equipment	EUR 56.5B
Shareholders' equity	EUR 43.9B
Tangible book value	EUR 42.8B
Tangible book value per share	EUR 58.44
Total assets	EUR 64.9B
Total cash	EUR 2B
Total debt	EUR 18.6B
Total liabilities	EUR 21B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.21
Current ratio	3.18
Net working capital	EUR 3.4B
Quick ratio	1.92
Working capital	EUR 5.3B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-10.89%
Dividend growth	5%
Dividend growth (10Y)	-1.47%
Dividend growth (3Y)	4.9%
Dividend growth (5Y)	5.25%
Dividend growth years	2
Dividend payment date	2026-08-20
Dividend payment years	22
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.63
Dividend yield	1.3%
Ex-dividend date	2026-08-12
Last dividend	EUR 0.74
Payout ratio	126.43%
Shareholder yield	-9.59%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	232.95%
10Y return CAGR	16.9%
10Y total return	376.56%
150-day SMA	EUR 194.81
15Y price change	491.25%
15Y return CAGR	17.2%
15Y total return	981.82%
1D price change	-4.29%
1M price change	4.48%
1M total return	4.48%
1W price change	0.33%
1W total return	0.33%
1Y price change	38.56%
1Y return CAGR	40.63%
1Y total return	40.59%
20-day SMA	EUR 205.34
200-day SMA	EUR 188.64
20Y price change	543.03%
20Y return CAGR	14.82%
20Y total return	1,485.02%
3M price change	-4.37%
3M total return	-4.01%
3Y price change	169.43%
3Y return CAGR	41.89%
3Y total return	185.73%
50-day SMA	EUR 204.34
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 225.70
52-week high date	2026-07-28
52-week low	EUR 150.30
52-week low date	2025-10-29
5Y price change	207.09%
5Y return CAGR	28.21%
5Y total return	246.34%
6M price change	18.91%
6M total return	19.77%
All-time high	EUR 225.70
All-time high date	2026-07-28
All-time low	EUR 20.99
All-time low date	2009-03-06
Average true range (ATR)	EUR 3.97
Average volume	35.9
Change from 52-week high	-10.01%
Change from 52-week low	35.13%
Change from all-time high	-5.98%
Change from all-time low	910.96%
Change from open	-5.31%
Day's gap	1.08%
High price	EUR 214.50
Low price	EUR 202.10
Monthly RSI	71.68
Open price	EUR 214.50
Position in 52-week range	8.06%
Previous close	EUR 212.20
Price vs 150-day SMA	8.93%
Price vs 20-day SMA	3.34%
Price vs 200-day SMA	12.49%
Price vs 50-day SMA	3.85%
Relative volume	19.44
RSI	43.63
Sharpe ratio	1.14
Sharpe ratio (3Y)	1.43
Sharpe ratio (5Y)	0.9
Sortino ratio	1.94
Sortino ratio (3Y)	2.48
Sortino ratio (5Y)	1.58
Volume	0
Weekly RSI	54.39
YTD price change	32.54%
YTD total return	33.97%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	719.7M
Shares change (QoQ)	2.3%
Shares change (YoY)	10.89%
Shares held by insiders	0.04%
Shares held by institutions	98.37%
Short ratio	6 days

Deeper analysis on FRA/HCW

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/HCW report

Is a complete FRA/HCW research report available?

No complete published report is available for fra/HCW (FRA/HCW) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/HCW (FRA/HCW)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/HCW

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/HCW indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/HCW

Frequently asked questions